BMS-961955

CAS No. 1431328-92-5

BMS-961955( BMS961955 )

Catalog No. M11828 CAS No. 1431328-92-5

BMS-961955 is an potent, allosteric inhibitor of HCV NS5B polymerase with EC50 of 7.9/4.3 nM for GT 1b/1a replicon respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1773 Get Quote
50MG 3582 Get Quote
100MG 4950 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BMS-961955
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS-961955 is an potent, allosteric inhibitor of HCV NS5B polymerase with EC50 of 7.9/4.3 nM for GT 1b/1a replicon respectively.
  • Description
    BMS-961955 is an potent, allosteric inhibitor of HCV NS5B polymerase with EC50 of 7.9/4.3 nM for GT 1b/1a replicon respectively; shows weak activity against PXR; displayes significantly enhanced metabolic stability in CLM and HLM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BMS961955
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    HCV
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    1431328-92-5
  • Formula Weight
    658.833
  • Molecular Formula
    C37H43FN4O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1(CC1)S(=O)(=O)NC(=O)C2=CC3=C(C=C2)C(=C4N3CC5(CC5C6=C4C=CC(=C6)F)C(=O)N7C8CCC7CN(C8)C)C9CCCCC9
  • Chemical Name
    (4bS,5aR)-12-Cyclohexyl-3-fluoro-4b,5,5a,6-tetrahydro-N-[(1-methylcyclopropyl)sulfonyl]-5a-[(3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl]cycloprop[d]indolo[2,1-a][2]benzazepine-9-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zheng BZ, et al. Bioorg Med Chem Lett. 2017 Jun 11. pii: S0960-894X(17)30626-1.
molnova catalog
related products
  • Combretastatin A4

    Combretastatin A4 is a microtubule-targeting agent that binds β-tubulin (Kd: 0.4 μM).

  • GSK-2485852

    GSK-2485852 (GSK2485852, GSK5852)?is a highly potent, selective HCV NS5B polymerase inhibitor with IC50 of 3.0 and 1.6 nM for HCV genotypes 1a and 1b in replicon assay, respectively.

  • Sofosbuvir

    Sofosbuvir (PSI-7977, GS-7977) is a HCV NS5B polymerase inhibitor for the treatment of chronic hepatitis C virus (HCV) infection.